RT Book, Section
A1 Iyer, Sriram
A1 Roubin, Gary
A1 Olin, Jeffrey W.
A2 Fuster, Valentin
A2 Harrington, Robert A.
A2 Narula, Jagat
A2 Eapen, Zubin J.
SR Print(0)
ID 1161720798
T1 CAROTID ARTERY STENTING
T2 Hurst's The Heart, 14e
YR 2017
FD 2017
PB McGraw-Hill Education
PP New York, NY
SN 9780071843249
LK accessmedicine.mhmedical.com/content.aspx?aid=1161720798
RD 2024/04/19
AB Stroke  is  the  fifth1  leading  cause  of  death  in  the  United  States  and  represents  the  single  most  important  cause  of  long-term  physical  and  intellectual  disability.  Each  year  in  the  United  States,  approximately  795,000  people  experience  a  new  or  recurrent  stroke  (87%  ischemic,  13%  hemorrhagic),  and  roughly  610,000  (75%)  of  these  strokes  are  first  events.  On  average,  every  40  seconds  someone  in  the  United  States  experiences  a  stroke;  there  are  close  to  130,000  annual  deaths  related  to  stroke,  and  the  cost  of  managing  stroke  patients  in  the  United  States  in  2012  was  approxinately  $33  billion.1  Unfortunately,  despite  important  advances  and  progress  in  several  areas  of  medicine,  the  treatment  options  for  an  established  stroke  are  limited  and  the  expectation  for  reversibility  or  improvement  of  stroke-related  neurological  deficits  is  both  guarded  and  unpredictable.